Abstract
Many drugs and other procedures produce all or part of their effects on smooth muscle indirectly, by modifying the release of catecholamines from adrenergic nerve terminals. (The loci and mechanisms of action of such drugs are discussed in Part II, Chapter 5) The estimation of the catecholamine contents of smooth muscles and of their perfusates or bathing media is thus frequently an important part of the study of drugs acting on smooth muscle.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anton, A. H. and Sayre, D. F. 1962. A study of the factors affecting the aluminium oxidetrihydroxyindole procedure for the analysis of catecholamines.Pharmac. Exp. Ther.138: 360–375.
Anton, A. H. and Sayre, D. F. 1968. Possible sources of error in solvent extraction procedures for catecholamines. Eur. J. Pharmac.4:435–440.
Burnstock, G. 1969. Evolution of the autonomic innervation of visceral and cardiovascular systems in vertebrates. Pharmac. Rev., 21: 247–324.
Engelman, K. and Portnoy, B. 1970. A sensitive double-isotope derivative assay for norepinephrine and epinephrine. Circ. Res., 26:53–57.
Engelman, K., Portnoy, B., and Lovenberg, W. 1968. A sensitive and specific double-isotope derivative method for the determination of catecholamines in biological specimens. Am. J. Med. Sci.255:259- 268.
Euler, U. S., von and Lishajko, F. 1961. Improved technique for the fluorimetric estimation of catecholamines. Acta Physiol. Scand.51:348–355.
Gaddum, J. H. and Lembeck, F. 1949. The assay of substances from the adrenal medulla.Br. J. Pharmac., 4:401–408.
Häggendal, J. 1962. On the use of strong exchange resins for determinations of small amounts of catechol amines. Scand. J. Clin. LahInvest.14:537–544.
Häggendal, J. 1966. Newer developments in catecholamine assay. Pharmac. Rev.18:325–329.
Hughes, J. 1972. Evaluation of mechanisms controlling the release and inactivation of the adrenergic transmitter in the rabbit portal vein and vas deferens. Britt.J.Pharmac.44:472–491.
Iversen, L. L. 1963. The uptake of noradrenaline by the isolated perfused rat heart. Br. J. Pharmac. Chemother.21:523–537.
Iversen, L. L. 1967. The Uptake and Storage of Noradrenaline, pp. 5–16, Cambridge University, London.
Iversen, L. L. and Jarrott, B. 1970. Modification of an enzyme radiochemical assay procedure for noradrenaline. Biochem. Pharmac., 19:1841–1843.
Kopin, I. J. 1968. False adrenergic transmitters. Ann. Rev. Pharmac., 8:377–394.
Koslow, S. H., Cattabeni, F., and Costa, E. 1972. Norepinephrine and dopamine: assay by mass fragment ography in the picomole range. Science, 176:177–180.
Kovacsics, G. B. and Saelens, J. K. 1968. Measurement of the levels and turnover of norepinephrine in discrete areas of rat brain using an enzymic assay. Arch. Int. Pharmacodyn.174:481–490.
Laverty, R. and Taylor, K. M. 1968. The fluorimetric assay of catecholamines and related compounds: improvements and extensions to the hydroxyindole technique. Anal. Biochem., 22:269–279.
Mann, M. and West, G. B. 1950. The nature of hepatic and splenic sympathin. Br. J. Pharmac. Chemother., 5:173–177.
Merrills, R. J. 1962. An autoanalytical method for the estimation of adrenaline and noradrenaline. Nature, 193:988.
Nikodijevic, B., Daly, J., and Creveling, C. R. 1969. Catechol-O-methyl transferase. I. An enzymatic assay for cardiac norepinephrine. Biochem. Pharmac.18:1577–1584.
Roberts, D. J. (with an addendum by Vogt, M.) 1964. Some possible causes of pharmacological activity in blank eluates following the separation of sympathomimetic catecholamines by paper chromatography. J. Pharm. Pharmac.16:313–322.
Saelens, J. K., Schoen, M. S., and Kovacsics, G. B. 1967. An enzymatic assay for norepinephrine in brain tissue. Biochem. Pharmac.16:1043–1049.
Schumann, H. J. 1959. Über den Hydroxytyramine Gebalt der Organe. Arch. Exp. Path. Pharmak.236:474–482.
Sharman, D. F. 1971. Methods of determination of catecholamines and their metabolites. In: Methods and Techniques of Neuro sciences, pp. 83–127. Ed. by Fried, R. Marcel Dekker, New York.
Shaw, F. H. 1938. The estimation of adrenaline. Biochem. J., 32:19–25.
Shote, P. A. and Olin, J. S. 1958. Identification and chemical assay of norepinephrine in brain and other tissues. J. Pharmac. Exp. Ther., 122:295–300.
Udenfriend, S. 1962. Fluoroescence Assay in Biology and Medicine. Academic Press, New York.
Vane, J. R. 1964. The use of isolated organs for detecting active substances in the circulating blood. Br. J. Pharmac.23:360–373.
Vane, J. R. 1966. The estimation of catecholamines by biological assay. Pharmac. Rev.18:317–324.
Vane, J. R. 1969. The release and fate of vaso-active hormones in the circulation. Br. J. Pharmac.35:209- 242.
Vogt, M. 1971. Bioassay. In: Handbuch, der Exper. Pharmak., 28/2, pp. 108–117.
Weil-Malherbe, H. 1959. The fluorimetric estimation of catechol compounds by the ethylenediamine condensation method. Pharmac. Rev.11:278–288.
Weil-Malherbe, H. 1968. The estimation of total (free + conjugated) catecholamines and some catecholamine metabolites in human urine. In: Methods of Biochemical Analysis, Vol. 16, pp. 293–326. Ed. by Glick, D. Wiley, New York.
Weil-Malherbe, H. 1971. Determination of catechol amines. In: Analysis of Biogenic Amines and Their Related Enzymes, pp. 119–152. Ed. by Glick, D. Wiley, New York.
Weil-Malherbe, H. and Bone, A. D. 1952. The chemical estimation of adrenaline-like substances in blood. Biochem. J.51:311–318.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Plenum Press, New York
About this chapter
Cite this chapter
Paton, D.M. (1975). Measurement of Catecholamines. In: Daniel, E.E., Paton, D.M. (eds) Smooth Muscle. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-2751-6_33
Download citation
DOI: https://doi.org/10.1007/978-1-4684-2751-6_33
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-2753-0
Online ISBN: 978-1-4684-2751-6
eBook Packages: Springer Book Archive